Clinical Trials Directory

Trials / Completed

CompletedNCT04431804

THYME AND CARVACROLL Nanoparticle Effect on Fungi

Effect of Thyme and Carvacroll Nanoparticles on Aspergillus Fumigatus Isolate From Intensive Care Patients

Status
Completed
Phase
Study type
Observational
Enrollment
210 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

Invasive Aspergillosis (IA) has increasingly been recognized as an emerging disease of non-neutropenic patients and in patients admitted to the ICU, even in the absence of an apparent predisposing immune-deficiency, with incidence ranges from 0.3% to 5.8% with an overall mortality rate exceeding 80%.

Conditions

Interventions

TypeNameDescription
OTHERsilver nanoparticlefungicidal effect of silver nanoparticles on aspergillus isolates

Timeline

Start date
2020-06-11
Primary completion
2020-09-20
Completion
2020-09-30
First posted
2020-06-16
Last updated
2020-11-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04431804. Inclusion in this directory is not an endorsement.